Japanese trading company Sojitz Corp. has acquired Singapore’s Royal Healthcare for an undisclosed sum, adding the multi-specialty provider to its growing healthcare portfolio.
Royal Healthcare, founded in 2002, will become a consolidated subsidiary of Sojitz as the Japanese firm expands its footprint in premium medical services across developed markets. The Singaporean company operates from the Royal Square Medical Centre, offering specialized treatments across cardiology, ophthalmology, gastroenterology and other fields.
The acquisition aligns with Sojitz’s strategy to strengthen its presence in high-value healthcare segments in developed countries with aging populations. The company has identified healthcare as a growth sector alongside renewable energy, making several investments in medical startups and service providers since 2017.
This purchase follows Sojitz’s earlier stake in primary healthcare provider Qualitas, which operates approximately 300 clinics across Malaysia, Singapore, and Australia, serving a market valued at $33.3 billion in 2020.
Industry analysts note that Sojitz is positioning itself to capitalize on growing demand for advanced medical services in Asia-Pacific’s affluent markets, where an expanding middle class and aging demographics are creating opportunities for premium healthcare operators.
